Effectiveness of Rituximab in the treatment of a rare overlap syndrome - Rheumatoid Arthritis/S. Sjogren/Systemic Sclerosis- complicated by monoclonal gammopathy;Efficacia del trattamento con Rituximab in una paziente affetta da rara sindrome overlap - Artrite Reumatoide/S.Sjogren/Sclerosi Sistemica Limitata -Complicata da gammapatia monoclonale

Trends in Medicine

Volumn 9, Issue 3, 2009, Pages 161-162

  Caliri, Annalisa ^a   Sangari, Donatella ^a   Sferrazza, Pamela ^a   Bagnato, GianFilippo ^a  

^a UNIVERSITY OF MESSINA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; C REACTIVE PROTEIN; CORTICOSTEROID; CYCLOSPORIN; ETANERCEPT; INFLIXIMAB; LEFLUNOMIDE; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; RITUXIMAB;

ADULT; ARTICLE; CASE REPORT; DISEASE ACTIVITY; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HUMAN; MONOCLONAL IMMUNOGLOBULINEMIA; RHEUMATOID ARTHRITIS; SJOEGREN SYNDROME; SYSTEMIC SCLEROSIS; TREATMENT OUTCOME;

EID: 76149113905     PISSN: 15942848     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (2)

1. Rodríguez-Reyna TS, Alarcón-Segovia D. Overlap syndromes in the context of shared autoimmunity. Autoimmunity 2005; 38:219-223.
2. Mease PJ. B cell-targeted therapy in autoimmune disease: rationale, mechanisms, and clinical application. J Rheumatol 2008; 35:1245-1255.